Baba T, Fukui M, Sakata S, Tashima T, Takeshita I, Nakamura T, Inoue T
Department of Neurosurgery, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Acta Neurochir (Wien). 1989;101(1-2):66-74. doi: 10.1007/BF01410072.
We studied the effect of intravenous and intracarotid infusion of adenosine and adenosine triphosphate (ATP) on the regional blood flow of intracerebrally transplanted RG-C6 tumours in rats, using the hydrogen clearance method. The intracarotid administration of adenosine or ATP selectively increased blood flow in the tumour, but did not produce any significant change either in the regional cerebral blood flow of the extratumoural ipsilateral hemisphere or in the ipsilateral hemisphere without tumour. The intracarotid administration of ATP at a dose of 10 micrograms/kg/min produced the most effective increase in the tumour blood flow (+51.5 +/- 16.8%). In contrast, both the intravenous administration of adenosine and that of ATP failed to increase tumour blood flow. These results may possibly indicate that intracarotid administration of the adenosine or ATP might contribute in selectively enhancing the delivery of anti-cancer agents to malignant brain tumours.
我们采用氢清除法研究了静脉内和颈内动脉输注腺苷及三磷酸腺苷(ATP)对大鼠脑内移植的RG - C6肿瘤局部血流的影响。颈内动脉给予腺苷或ATP可选择性增加肿瘤内的血流,但对肿瘤同侧半球瘤外区域的脑血流量或无肿瘤的同侧半球均未产生任何显著变化。以10微克/千克/分钟的剂量颈内动脉给予ATP可使肿瘤血流增加最为有效(增加51.5±16.8%)。相比之下,静脉内给予腺苷和ATP均未能增加肿瘤血流。这些结果可能表明,颈内动脉给予腺苷或ATP可能有助于选择性增强抗癌药物向恶性脑肿瘤的递送。